# INFINITY PHARMACEUTICALS, INC.

INFINITY PHARMACEUTICALS, INC. is a company headquartered in Cambridge, MA, United States.

## Company overview

- **Legal name:** INFINITY PHARMACEUTICALS, INC.
- **Former names in filing history:** DISCOVERY PARTNERS INTERNATIONAL INC (2000-06-23 to 2006-09-11)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Cambridge, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001113148

## About

INFINITY PHARMACEUTICALS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001113148, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-28, it reported annual revenue of USD 2,593,000; net income of USD -44,369,000; total assets of USD 42,151,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $2.6M (USD 2,593,000)
- **Net income:** -$44.4M (USD -44,369,000)
- **Total assets:** $42.2M (USD 42,151,000)
- **Cash and equivalents:** $38.3M (USD 38,313,000)
- **Operating cash flow:** -$42.4M (USD -42,431,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $1.9M (USD 1,858,000)
- **Net income:** -$45.3M (USD -45,262,000)
- **Total assets:** $84.8M (USD 84,785,000)
- **Cash and equivalents:** $80.7M (USD 80,726,000)
- **Operating cash flow:** -$40.6M (USD -40,618,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $1.7M (USD 1,719,000)
- **Net income:** -$40.5M (USD -40,492,000)
- **Total assets:** $39.3M (USD 39,319,000)
- **Cash and equivalents:** $28.6M (USD 28,593,000)
- **Operating cash flow:** -$35.7M (USD -35,739,000)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $3.0M (USD 3,049,000)
- **Net income:** -$47.1M (USD -47,057,000)
- **Total assets:** $49.0M (USD 49,014,000)
- **Cash and equivalents:** $22.3M (USD 22,260,000)
- **Operating cash flow:** -$41.5M (USD -41,530,000)

## Recent SEC filings

- Form 8-K — filed 2023-09-29 — period 2023-09-28 — 8-K
- Form 8-K — filed 2023-09-13 — period 2023-09-12 — 8-K
- Form 8-K — filed 2023-09-11 — period 2023-09-05 — 8-K
- Form 8-K — filed 2023-09-01 — period 2023-08-29 — 8-K
- Form 10-Q — filed 2023-08-10 — period 2023-06-30 — 10-Q
- Form 8-K — filed 2023-07-25 — period 2023-07-24 — 8-K
- Form 8-K — filed 2023-07-24 — period 2023-07-23 — 8-K
- Form 8-K — filed 2023-07-14 — period 2023-07-14 — 8-K
- Form 8-K — filed 2023-07-03 — period 2023-07-03 — 8-K
- Form 8-K — filed 2023-06-30 — period 2023-06-27 — 8-K
- Form 8-K — filed 2023-06-20 — period 2023-06-15 — 8-K
- Form 10-Q — filed 2023-05-09 — period 2023-03-31 — 10-Q

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/infinity-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology